LINC00355:8 promotes cell proliferation and migration with invasion <i>via</i> the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma

Zhou, Fangyuan; Lei, Yiming; Xu, Xuan; Zhou, Haoxiong; Liu, Huiling; Jiang, Jie; Yang, Yidong; Wu, Bin

doi:10.7150/jca.43831



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2020; 11(19):5641-5655. doi:10.7150/jca.43831 This issue Cite

Research Paper

LINC00355:8 promotes cell proliferation and migration with invasion via the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma

Fangyuan Zhou^*, Yiming Lei^*, Xuan Xu, Haoxiong Zhou, Huiling Liu, Jie Jiang, Yidong Yang^✉, Bin Wu^✉

Department of Gastroenterology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
*These authors contributed equally to this work.

Citation:

Zhou F, Lei Y, Xu X, Zhou H, Liu H, Jiang J, Yang Y, Wu B. LINC00355:8 promotes cell proliferation and migration with invasion via the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma. J Cancer 2020; 11(19):5641-5655. doi:10.7150/jca.43831. https://www.jcancer.org/v11p5641.htm

Other styles

Abstract

Background: Recent studies have reported that various long non-coding RNAs (lncRNAs) promote hepatocellular carcinoma (HCC) progression, and our previous study indicated that lncRNA LINC00355:8 is overexpressed in HCC. However, the role of LINC00355:8 in HCC is unclear. The primary aim of this study was to explore the biological role of LINC00355:8 in HCC.

Methods: Microarray analysis was performed to explore the aberrantly expressed lncRNAs in HCC compared with precancerous tissues. Real-time PCR and in situ hybridization were used to investigate the expression of LINC00355:8 in HCC tissues. CCK8, EdU, colony formation, wound healing and transwell assays were performed to analyse cell proliferation, migration and invasion. A xenograft tumour model was established to analyse the effect of LINC00355:8 on tumour growth in vivo. Luciferase assays were utilized to explore the binding sites between miR-6777-3p and other genes, such as LINC00355:8 and Wnt10b. After cell transfection, the protein expression levels of Wnt10b, β-catenin, E-cadherin, N-cadherin, c-Myc and Snail were determined by Western blotting.

Results: The present study revealed that LINC00355:8 was significantly upregulated in HCC, promoted HCC cell proliferation, migration and invasion in vitro and enhanced tumour growth in vivo. LINC00355:8 regulated miR-6777-3p expression by acting as a ceRNA, and the expression of Wnt10b was negatively modulated by miR-6777-3p. Moreover, LINC00355:8 could activate the Wnt/β-catenin signalling pathway and promote EMT progression by inhibiting the miR-6777-3p/Wnt10b interaction in HCC.

Conclusion: Our findings indicate that LINC00355:8 activates Wnt10b and promotes HCC progression via the suppression of miR-6777-3p, which may provide novel therapeutic targets for HCC.

Keywords: Hepatocellular carcinoma, LINC00355:8, miR-6777-3p, Wnt10b

Citation styles

APA

Zhou, F., Lei, Y., Xu, X., Zhou, H., Liu, H., Jiang, J., Yang, Y., Wu, B. (2020). LINC00355:8 promotes cell proliferation and migration with invasion via the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma. Journal of Cancer, 11(19), 5641-5655. https://doi.org/10.7150/jca.43831.

ACS

Zhou, F.; Lei, Y.; Xu, X.; Zhou, H.; Liu, H.; Jiang, J.; Yang, Y.; Wu, B. LINC00355:8 promotes cell proliferation and migration with invasion via the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma. J. Cancer 2020, 11 (19), 5641-5655. DOI: 10.7150/jca.43831.

NLM

CSE

Zhou F, Lei Y, Xu X, Zhou H, Liu H, Jiang J, Yang Y, Wu B. 2020. LINC00355:8 promotes cell proliferation and migration with invasion via the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma. J Cancer. 11(19):5641-5655.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.